Clinical trials
Multiple Sclerosis trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
108 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 10 |
| 2018 | 8 |
| 2019 | 10 |
| 2020 | 8 |
| 2021 | 13 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 4 |
| 2025 | 8 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Recruiting | 21 |
| Unknown status | 19 |
| Terminated | 8 |
| Active, not recruiting | 5 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 12 |
| University Hospital, Bordeaux | 11 |
| Lille Catholic University | 9 |
| Assistance Publique Hopitaux De Marseille | 7 |
| Nantes University Hospital | 6 |
| Centre Hospitalier Universitaire de Nīmes | 5 |
| Rennes University Hospital | 5 |
| Institut National de la Santé Et de la Recherche Médicale, France | 4 |
| University Hospital, Caen | 4 |
| University Hospital, Clermont-Ferrand | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 108 |
| Multiple Sclerosis, Relapsing-Remitting | 8 |
| Cognitive Dysfunction | 6 |
| Muscle Spasticity | 5 |
| Spinal Cord Injuries | 5 |
| Stroke | 5 |
| Nervous System Diseases | 4 |
| Optic Neuritis | 4 |
| Arthritis, Rheumatoid | 3 |
| Demyelinating Diseases | 3 |
Trials
Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.
8 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.